MaltSci 麦伴科研

Appearance

Popular Reports / Emerging Frontiers

This report is written by MaltSci based on the latest literature and research findings

How are biomaterials used in regenerative medicine? ​

Abstract ​

Regenerative medicine is a rapidly evolving field that aims to repair, replace, or regenerate damaged tissues and organs, ultimately restoring normal physiological functions. Central to this innovative discipline is the use of biomaterials—engineered substances designed to interact with biological systems for medical purposes. Biomaterials can be derived from natural sources or synthesized artificially, and they are meticulously crafted to facilitate tissue regeneration by providing structural support, delivering bioactive molecules, or promoting cellular interactions. This review categorizes the types of biomaterials utilized in regenerative medicine, including natural, synthetic, and composite biomaterials, and explores their mechanisms of action, focusing on biocompatibility, drug delivery capabilities, and cellular interactions. Applications of biomaterials span a diverse range of medical areas, including wound healing, bone regeneration, cartilage repair, and organ transplantation. Challenges faced in biomaterial development, such as material selection and regulatory hurdles, are also discussed. The review concludes by outlining future directions for research and development in this exciting field, emphasizing the potential of biomaterials to revolutionize regenerative medicine and enhance therapeutic strategies.

Outline ​

This report will discuss the following questions.

  • 1 Introduction
  • 2 Types of Biomaterials
    • 2.1 Natural Biomaterials
    • 2.2 Synthetic Biomaterials
    • 2.3 Composite Biomaterials
  • 3 Mechanisms of Action
    • 3.1 Biocompatibility and Bioactivity
    • 3.2 Drug Delivery Systems
    • 3.3 Cellular Interactions and Tissue Integration
  • 4 Applications in Regenerative Medicine
    • 4.1 Wound Healing
    • 4.2 Bone Regeneration
    • 4.3 Cartilage Repair
    • 4.4 Organ and Tissue Engineering
  • 5 Challenges and Future Directions
    • 5.1 Material Selection and Design
    • 5.2 Regulatory Hurdles
    • 5.3 Emerging Technologies and Innovations
  • 6 Conclusion

1 Introduction ​

Regenerative medicine is a rapidly evolving field that aims to repair, replace, or regenerate damaged tissues and organs, ultimately restoring normal physiological functions. Central to this innovative discipline is the use of biomaterials—engineered substances designed to interact with biological systems for medical purposes. Biomaterials can be derived from natural sources or synthesized artificially, and they are meticulously crafted to facilitate tissue regeneration by providing structural support, delivering bioactive molecules, or promoting cellular interactions [1][2]. The significance of biomaterials in regenerative medicine cannot be overstated, as they serve as critical scaffolds that guide tissue formation and organization, mimicking the extracellular matrix (ECM) at the nanometer scale [1].

The application of biomaterials spans a diverse range of medical areas, including wound healing, bone regeneration, cartilage repair, and organ transplantation [3][4]. Recent advancements in biomaterial technology have led to the development of sophisticated constructs that not only support cellular functions but also enhance the body’s innate healing capabilities [5][6]. This progress is pivotal in addressing the limitations of traditional medical approaches, which often rely on passive replacement of damaged tissues rather than actively promoting regeneration [7]. The integration of biomaterials into regenerative strategies is proving to be a transformative force, paving the way for novel therapeutic solutions that harness the body’s own repair mechanisms [8].

Current research in biomaterials has identified several key mechanisms through which these materials exert their effects. Understanding the interactions between biomaterials and biological systems is essential for optimizing their design and functionality. These interactions can be influenced by the physical and chemical properties of the materials, including biocompatibility, bioactivity, and the ability to modulate immune responses [9][10]. As we delve deeper into the nuances of cell-biomaterial interactions, we are uncovering new strategies to enhance tissue integration and improve regenerative outcomes [10][11].

This review will be organized as follows: First, we will categorize the types of biomaterials utilized in regenerative medicine, distinguishing between natural, synthetic, and composite biomaterials. Next, we will explore the mechanisms of action of these biomaterials, focusing on their biocompatibility, drug delivery capabilities, and interactions with cells that facilitate tissue integration. Subsequently, we will discuss the various applications of biomaterials in regenerative medicine, including their roles in wound healing, bone regeneration, cartilage repair, and organ engineering. Furthermore, we will address the challenges currently faced in biomaterial development, such as material selection, regulatory hurdles, and the need for innovative technologies. Finally, we will outline future directions for research and development in this exciting field, emphasizing the potential of biomaterials to revolutionize regenerative medicine and enhance therapeutic strategies.

In summary, the integration of biomaterials into regenerative medicine represents a significant leap forward in our ability to repair and regenerate tissues. By understanding and harnessing the properties of these materials, we can develop more effective and targeted approaches to treating a variety of medical conditions, ultimately improving patient outcomes and quality of life [12].

2 Types of Biomaterials ​

2.1 Natural Biomaterials ​

In regenerative medicine, biomaterials play a crucial role in restoring and repairing damaged tissues and organs. They are utilized to create scaffolds that mimic the extracellular matrix (ECM), providing a supportive environment for cell attachment, proliferation, and differentiation. Among the various types of biomaterials, natural biomaterials are particularly significant due to their inherent biocompatibility and ability to interact with biological systems.

Natural biomaterials, derived from biological sources, exhibit properties that closely resemble those of the native ECM, which is essential for effective tissue regeneration. These materials can include proteins, polysaccharides, and other biomacromolecules that are critical for cell behavior and tissue formation. For instance, collagen, a predominant protein in the ECM, serves as an excellent scaffold material because of its ability to promote cell adhesion and support tissue development [3].

The application of natural biomaterials in regenerative medicine is driven by their ability to enhance the body's natural healing processes. They can be engineered to release growth factors and cytokines in response to physiological signals, thereby imitating the natural healing process and promoting rapid tissue regeneration while minimizing scarring [13]. Furthermore, these biomaterials can be modified to improve their mechanical properties and degradation rates, allowing them to provide the necessary structural support during the healing process before being gradually replaced by natural tissue [14].

Additionally, natural biomaterials are often utilized in combination with other materials or technologies to enhance their functionality. For example, the incorporation of antimicrobial agents into natural biomaterials can prevent infections, which is particularly important in applications such as bone grafts [15]. The development of nanostructured natural biomaterials has also been explored, as these materials can mimic the nanoscale features of the ECM and actively regulate cellular responses, including differentiation and matrix deposition [1].

Challenges in the use of natural biomaterials include ensuring their consistent quality and performance, as well as addressing potential immunogenic responses. Nevertheless, the continued research and development in this area aim to optimize the properties of natural biomaterials to enhance their efficacy in clinical applications, thereby advancing the field of regenerative medicine [8].

In summary, natural biomaterials are integral to regenerative medicine due to their ability to mimic the ECM, promote cellular interactions, and facilitate tissue repair and regeneration. Their unique properties and versatility make them a focal point for ongoing research aimed at improving therapeutic outcomes in tissue engineering and regenerative therapies.

2.2 Synthetic Biomaterials ​

Biomaterials play a crucial role in regenerative medicine, serving as scaffolds that support tissue repair and regeneration. Among the various categories of biomaterials, synthetic biomaterials are particularly significant due to their tailored properties and functionalities that can be designed to meet specific medical needs.

Synthetic biomaterials, including polymers such as polylactic acid (PLA), polyurethane, and polyethylene terephthalate (PET), have been extensively utilized in regenerative medicine. These materials are favored for their ability to be engineered with precise mechanical and degradation properties, allowing for customized applications in tissue engineering. They can be processed into various forms, such as hydrogels, nanofibers, and three-dimensional scaffolds, which are essential for creating a supportive environment for cell growth and tissue formation (Steffens et al. 2018) [16].

One of the primary advantages of synthetic biomaterials is their versatility in design. They can be modified to mimic the characteristics of the natural extracellular matrix (ECM), thereby enhancing cell attachment, proliferation, and differentiation. This mimicking effect is critical as it allows the synthetic scaffolds to induce natural developmental and wound healing processes, thereby facilitating effective tissue regeneration (Ma 2008) [17]. Additionally, advancements in materials science have led to the development of biodegradable polymers that not only serve as temporary scaffolds but also gradually degrade to be replaced by newly formed tissue, minimizing the need for secondary surgeries to remove implants (Wang et al. 2024) [18].

Recent innovations in synthetic biomaterials also include the incorporation of bioactive components that can release growth factors or other therapeutic agents in response to physiological signals. This capability can enhance the regenerative potential of the biomaterials, allowing for a more dynamic interaction with the biological environment (Andreadis & Geer 2006) [19]. For example, nanostructured biomaterials have been shown to regulate cellular responses actively, such as cell attachment and matrix deposition, thus promoting tissue regeneration more effectively than traditional materials (Wei & Ma 2008) [1].

Furthermore, the integration of nanotechnology into the development of synthetic biomaterials has led to the creation of nanoengineered scaffolds that can modulate cellular behavior at the molecular level. These advanced materials can be designed to possess specific porosity and surface characteristics, which can significantly influence cellular responses and tissue integration (Brokesh & Gaharwar 2020) [5].

In conclusion, synthetic biomaterials are integral to the field of regenerative medicine due to their customizable properties, ability to mimic natural tissue environments, and potential for bioactivity. Their ongoing development and application are paving the way for innovative solutions in tissue engineering and regenerative therapies, addressing the challenges of tissue loss and dysfunction in clinical settings.

2.3 Composite Biomaterials ​

Biomaterials are integral to the field of regenerative medicine, serving various roles in the repair and regeneration of damaged tissues and organs. Composite biomaterials, in particular, represent a significant advancement in this area, combining multiple materials to leverage their individual properties and enhance overall functionality.

Composite biomaterials are engineered from two or more distinct materials to create a product that exhibits improved mechanical, physical, and biological properties compared to its individual components. In regenerative medicine, these materials can provide scaffolding that supports cell attachment, proliferation, and differentiation, essential for tissue regeneration. For instance, the incorporation of collagen and chitosan into composite biomaterials has shown promise due to their biocompatibility and ability to mimic the extracellular matrix (ECM), which is crucial for tissue engineering applications [1].

The functionalization of composite biomaterials can significantly enhance their application in regenerative medicine. For example, a study highlighted the creation of a collagen-chitosan composite biomaterial functionalized with clotrimazole, which exhibited antibacterial, antifungal, and antitumor activities. This composite was characterized by its porous structure, facilitating cell infiltration and nutrient exchange, and demonstrated antimicrobial activity against pathogens such as Candida albicans and Staphylococcus aureus [20]. Such functionalized composites can not only support tissue regeneration but also actively prevent infections, which is a common complication in regenerative procedures.

Furthermore, composite biomaterials can be designed to mimic the microenvironment of specific tissues. For instance, biomaterials that incorporate bioactive ions released from inorganic components have been shown to modulate cellular responses, influencing cell identity and promoting tissue-specific functions. This is particularly relevant in bone tissue engineering, where composites that include hydroxyapatite and other minerals can enhance osteogenic differentiation and support bone regeneration [5].

In the context of cardiac stem cell therapy, composite biomaterials have been utilized to create scaffolds that promote angiogenesis and enhance the engraftment of transplanted cells. These biomaterials are designed to mimic the native cardiac microenvironment, thereby influencing the fate of stem cells and facilitating their differentiation into cardiac lineages [4].

The development of composite biomaterials is further supported by advancements in fabrication techniques, such as 3D printing, which allows for the precise control of material properties and the creation of complex structures that can replicate the architecture of natural tissues [15]. This capability is crucial for creating personalized implants that can better integrate with the host tissue.

In conclusion, composite biomaterials are pivotal in regenerative medicine due to their ability to combine multiple beneficial properties, support cellular activities, and enhance tissue regeneration. Their versatility and functionalization potential position them as key components in the development of advanced therapies aimed at repairing and regenerating damaged tissues. As research continues to evolve, the applications and effectiveness of composite biomaterials in regenerative medicine are expected to expand significantly.

3 Mechanisms of Action ​

3.1 Biocompatibility and Bioactivity ​

Biomaterials are integral to the field of regenerative medicine, serving multiple roles that encompass the regeneration and replacement of damaged or dysfunctional tissues. Their mechanisms of action are fundamentally linked to their biocompatibility and bioactivity, which facilitate interactions with biological systems to promote healing and tissue regeneration.

Biocompatibility refers to the ability of a biomaterial to perform its intended function without eliciting an adverse reaction from the host's immune system. It is crucial for ensuring that the biomaterials do not provoke significant inflammatory responses, which can lead to complications such as implant rejection or chronic inflammation. For instance, biomaterials designed for regenerative applications must ideally integrate well with living tissues, minimizing the foreign body response (FBR) that can occur at the material-tissue interface. A well-modulated immune response is essential for effective tissue regeneration, as it allows for the appropriate recruitment of cells involved in healing, such as macrophages and fibroblasts [9].

The bioactivity of biomaterials, on the other hand, pertains to their ability to interact with biological systems to stimulate cellular responses that are conducive to tissue repair and regeneration. Biomaterials can be engineered to release bioactive ions, such as calcium, magnesium, and zinc, which have been shown to influence cellular behavior and promote tissue-specific functions [5]. For example, bioactive glasses and ceramics have been identified as key materials that can guide the healing process through their inherent properties that promote osteogenesis and angiogenesis [21].

Moreover, the structural characteristics of biomaterials play a significant role in their bioactivity. Materials that mimic the extracellular matrix (ECM) at the nanoscale can actively regulate cellular responses, including attachment, proliferation, differentiation, and matrix deposition [1]. This mimicking of ECM properties is critical as it provides the necessary biochemical and mechanical cues that cells require to function optimally during the regeneration process.

Recent advancements in biomaterial technology have also highlighted the importance of immunomodulatory properties, where biomaterials are designed to modulate the immune response actively. This involves tuning the interactions between biomaterials and immune cells to foster a pro-regenerative environment while minimizing inflammatory responses [22]. The incorporation of specific modifications to biomaterials can enhance their ability to promote tissue integration and healing by leveraging the body's natural repair mechanisms [23].

In conclusion, the successful application of biomaterials in regenerative medicine hinges on their biocompatibility and bioactivity. Understanding the interactions between biomaterials and biological systems allows for the design of materials that not only serve as scaffolds for tissue regeneration but also actively participate in the healing process by modulating immune responses and promoting cellular activities essential for tissue repair [8]. This comprehensive approach to biomaterial design is paving the way for innovative therapies in regenerative medicine, facilitating improved outcomes in the treatment of various tissue injuries and defects.

3.2 Drug Delivery Systems ​

Biomaterials play a crucial role in regenerative medicine, particularly in the development of advanced drug delivery systems aimed at enhancing therapeutic outcomes. These systems leverage the unique properties of biomaterials to address the challenges associated with conventional pharmacological treatments, which often suffer from poor targeting, rapid clearance, and low therapeutic efficiency.

The mechanisms underlying the action of biomaterials in drug delivery systems primarily involve their ability to provide mechanical support, facilitate sustained release of bioactive molecules, and enhance intercellular contact, thereby reducing cell apoptosis and promoting functional recovery. For instance, biomaterials such as natural and synthetic polymers, inorganic materials, and hybrid systems are utilized to create advanced drug-delivery platforms including nanoparticles, hydrogels, and scaffold-based systems. These systems can be designed to mimic the extracellular matrix (ECM), which is vital for guiding tissue formation and organization during regeneration (Xu et al. 2025; Wei and Ma 2008).

The application of biomaterials in drug delivery is characterized by several innovative strategies. For example, lipid-based drug delivery systems have shown significant promise in regenerative medicine by protecting therapeutic proteins and peptides from degradation, while also ensuring controlled delivery (Filipczak et al. 2021). Moreover, hydrogels have gained attention due to their ability to mimic the native ECM, providing a conducive environment for cell proliferation and differentiation (Pishavar et al. 2021). These hydrogels can also facilitate localized drug delivery, thereby overcoming challenges related to inflammation and infection in tissue repair processes.

Recent advancements in biomaterials have led to the development of multifunctional and self-healable hydrogels that not only serve as drug delivery vehicles but also promote tissue regeneration. These materials are designed to respond to physiological cues, enabling controlled release of therapeutic agents and enhancing the therapeutic efficacy of treatments (Pishavar et al. 2021). Furthermore, the integration of biomaterials with stem cell therapies has shown potential in improving cell survival, differentiation, and engraftment, thereby augmenting the regenerative capabilities of these therapies (Rasekh et al. 2025).

However, the field faces significant challenges, including the need for improved targeting and precision in drug delivery, as well as the need to address issues related to immune reactions and degradation regulation of biomaterials (Xu et al. 2025; Shen et al. 2025). Future research is directed towards optimizing the properties of biomaterials, refining delivery mechanisms, and overcoming translational barriers to enhance their clinical applicability.

In summary, biomaterials serve as pivotal components in the advancement of drug delivery systems within regenerative medicine, facilitating targeted and effective delivery of therapeutic agents while promoting tissue repair and regeneration. Their versatility and adaptability are essential for developing innovative strategies that improve patient outcomes in various medical applications.

3.3 Cellular Interactions and Tissue Integration ​

Biomaterials are integral to regenerative medicine, serving as engineered materials designed to interact with living tissues to facilitate healing and tissue regeneration. Their mechanisms of action involve complex cellular interactions and the promotion of tissue integration, which are critical for the successful application of these materials in clinical settings.

The primary role of biomaterials in regenerative medicine is to mimic the natural extracellular matrix (ECM) and support the body's innate healing processes. Biomaterials can be classified as bio-inert or bioactive, where bio-inert materials integrate minimally with tissues, while bioactive materials actively influence biological responses, promoting tissue regeneration and healing (Bonferoni et al., 2021).

Cellular interactions between biomaterials and the host tissues begin with protein adsorption on the material surface, which is a critical first step that influences subsequent cellular behaviors such as cell adhesion, proliferation, and differentiation. The composition and surface characteristics of biomaterials, including topography, charge, and stiffness, play significant roles in modulating these cellular responses (Othman et al., 2018). Proteomics studies have highlighted the importance of understanding these interactions over time, as they can dictate the regenerative capabilities of biomaterials (Othman et al., 2018).

Moreover, the immune response elicited by biomaterials at the material-tissue interface is crucial. Biomaterials are recognized as foreign entities by the immune system, leading to a foreign body response (FBR) characterized by inflammation and the recruitment of immune cells, particularly macrophages. Recent research suggests that a balanced immune response, including appropriate macrophage polarization, is essential for facilitating tissue regeneration. For instance, biomaterials designed to promote anti-inflammatory responses can enhance tissue integration and minimize adverse effects associated with chronic inflammation (Ten Brink et al., 2024; Kim et al., 2023).

The dynamic interplay between biomaterials and the immune system is underscored by the discovery of the roles of neutrophils and other immune cells in tissue repair. These cells not only participate in the initial inflammatory response but also play pivotal roles in the resolution of inflammation and the promotion of tissue regeneration (Sousa & Barbosa, 2023). Understanding these immune interactions can guide the design of biomaterials that optimize the healing process by promoting a favorable immune environment (Karkanitsa et al., 2021).

In terms of specific applications, biomaterials are utilized to create scaffolds that provide structural support for cellular transplantation and tissue engineering. These scaffolds can enhance angiogenesis, influence cell migration, and improve the engraftment of transplanted cells, thereby playing a significant role in cardiovascular applications and other tissue regeneration strategies (Sahito et al., 2016). The design of biomaterials can also be tailored to release bioactive ions or molecules that further enhance cellular responses and promote tissue-specific functions (Brokesh & Gaharwar, 2020).

In summary, biomaterials in regenerative medicine function through intricate mechanisms involving cellular interactions and immune responses. By carefully designing biomaterials to optimize these interactions, researchers aim to enhance tissue integration, promote healing, and ultimately improve clinical outcomes in regenerative therapies. The ongoing exploration of these mechanisms will continue to drive advancements in biomaterial technologies and their applications in regenerative medicine (Cao & Ding, 2022; Zhu et al., 2023).

4 Applications in Regenerative Medicine ​

4.1 Wound Healing ​

Biomaterials play a crucial role in regenerative medicine, particularly in the domain of wound healing. Their application spans a variety of functions aimed at enhancing tissue repair, promoting healing processes, and addressing the challenges associated with chronic and acute wounds.

Wound healing is a complex biological process involving multiple stages: hemostatic, inflammatory, proliferative, and tissue remodeling. Biomaterials can significantly contribute to each of these phases by providing a supportive microenvironment conducive to healing. For instance, they can serve as scaffolds that mimic the extracellular matrix (ECM), promoting cell attachment, proliferation, and differentiation essential for tissue regeneration [23]. Furthermore, they can help control inflammation and infection, which are critical for successful healing [24].

The versatility of biomaterials allows for the incorporation of various therapeutic agents, including growth factors, antimicrobial agents, and bioactive compounds. These agents can be delivered in a sustained manner to the wound site, enhancing the healing process while reducing the need for frequent administration. For example, bioengineered materials that release growth factors and cytokines have shown promise in accelerating tissue regeneration and improving wound healing outcomes [25]. Additionally, the integration of antioxidant properties in biomaterials has been shown to support tissue regeneration by mitigating oxidative stress at the injury site [14].

Different types of biomaterials, including natural and synthetic polymers, have been extensively researched for their wound healing capabilities. Natural polymers such as chitosan, hyaluronic acid, and alginate are favored due to their biocompatibility and biodegradability [26]. These materials can be formulated into various forms such as hydrogels, films, and scaffolds, each tailored for specific wound types and healing stages [24].

Recent advancements have also led to the development of smart biomaterials that can respond to environmental stimuli, thus providing precise control over the healing process. These materials can adjust their properties based on the wound's condition, promoting a more personalized approach to wound management [24].

Moreover, the field is witnessing innovations such as living biomaterials, which combine living cells with biomaterials to enhance therapeutic efficacy. These materials aim to modulate the wound microenvironment actively and harness the body's natural healing processes [27].

In summary, biomaterials are integral to regenerative medicine, particularly in wound healing. They not only provide structural support and a conducive environment for cell behavior but also enhance healing through the controlled release of therapeutic agents and the modulation of inflammatory responses. Ongoing research continues to explore new biomaterials and their combinations to improve clinical outcomes and address the complexities of wound healing [28][29][30].

4.2 Bone Regeneration ​

Biomaterials play a pivotal role in regenerative medicine, particularly in the context of bone regeneration. The primary objective of these materials is to support the repair and regeneration of bone tissue affected by various traumas, diseases, or congenital anomalies. Recent advancements in biomaterials have expanded their applications, leading to significant improvements in the treatment of bone defects and enhancing the overall success of orthopedic therapies.

The evolution of biomaterials has transitioned from traditional grafting methods to innovative materials that address common limitations such as availability and rejection risks. For instance, the use of bioceramics, polymeric components, hydrogels, and nanofiber scaffolds has gained traction. These materials are designed to mimic the natural bone matrix, providing a suitable environment for cell adhesion, proliferation, and differentiation. They also support the vascularization of large tissue constructs, which is critical for successful bone regeneration [31].

A particularly promising area of research involves the incorporation of therapeutic ions into bone grafting materials. Ions such as strontium, copper, boron, and magnesium have been shown to enhance osteogenesis, promote angiogenesis, and improve overall bone healing outcomes. The precise introduction of these ions can significantly improve the performance of biomaterials, addressing the challenges associated with treating large and complex bone defects [32].

Nanotechnology has also emerged as a transformative approach in the development of bone regenerative biomaterials. Nanostructured materials can influence biological processes at the nanoscale, leading to enhanced biocompatibility and osteoinductivity. For example, nanomaterials have been utilized for targeted drug delivery systems that stimulate bone repair and regeneration, offering a new avenue for treatment [33].

Moreover, the interactions between biomaterials and stem cells are crucial for successful bone regeneration. Biomaterials not only provide a structural framework but also modulate the behavior of stem cells, guiding their differentiation into bone-forming cells. The design of biomaterials with specific physical and chemical properties can significantly influence the stem cell microenvironment, promoting optimal regeneration [34].

In addition to their structural roles, biomaterials can be engineered to possess immunomodulatory properties, which are essential in managing the inflammatory responses that occur during bone healing. The modulation of immune responses through biomaterial design can facilitate a more favorable healing environment, reducing the risks of infection and enhancing regeneration [35].

The integration of advanced imaging and computer-assisted techniques in the design of personalized implants and prosthetics further underscores the versatility of biomaterials in regenerative medicine. This approach allows for the creation of customized solutions that cater to individual patient needs, improving the efficacy of treatments [15].

Overall, the applications of biomaterials in regenerative medicine, particularly in bone regeneration, are vast and continually evolving. The combination of innovative material design, the incorporation of bioactive factors, and the strategic use of stem cells are setting the stage for revolutionary advancements in the management of bone defects, ultimately leading to safer and more effective therapeutic options [36].

4.3 Cartilage Repair ​

Biomaterials play a crucial role in regenerative medicine, particularly in the repair and regeneration of cartilage, which is notoriously difficult due to its avascular and aneural nature. The development and application of biomaterials in this context have advanced significantly, leveraging various strategies to enhance cartilage repair outcomes.

Articular cartilage injuries are prevalent and pose a significant challenge in musculoskeletal medicine due to the limited intrinsic regenerative capacity of cartilage. Current treatment modalities often yield unfavorable prognoses and complications, highlighting the need for innovative approaches[37]. Biomaterials serve as scaffolds that mimic the extracellular matrix (ECM), providing structural support for cell attachment, proliferation, and differentiation necessary for tissue regeneration[38].

The strategies for utilizing biomaterials in cartilage repair include regeneration, substitution, and immunization. Regenerative approaches often incorporate biologically active substances such as stem cells, growth factors, and extracellular vesicles (EVs) to promote chondrocyte activity and enhance the healing process[37]. For instance, the use of composite bioactive scaffolds, which combine mechanical support with bioactive factors, has shown promise in clinical applications for cartilage repair[39].

Recent advancements in tissue engineering have introduced innovative scaffold technologies, such as stimuli-responsive smart scaffolds and 3D-printed scaffolds, which can adapt to the mechanical environment and promote better integration with host tissues[37]. These scaffolds not only provide physical support but also facilitate biochemical interactions that are critical for cartilage regeneration[2].

Nanomaterials, characterized by their unique properties at the nanoscale, have emerged as powerful tools in cartilage repair. They can enhance the mechanical properties of scaffolds, optimize drug loading and bioavailability, and enable targeted delivery of therapeutic agents[40]. The integration of nanomaterials into biomaterials can improve scaffold-cell interactions and mimic the ECM environment more closely, thus enhancing the functionality of engineered tissue constructs[40].

Moreover, the incorporation of microenvironmental cues through biomaterials can significantly influence the healing process. For example, biomaterials can be designed to deliver growth factors in a controlled manner, promoting the proliferation and differentiation of chondrocytes, which is essential for effective cartilage repair[41]. The use of gene therapy in conjunction with biomaterials is also gaining traction, providing a means to enhance the regenerative capacity of the delivered cells and scaffolds[42].

In summary, biomaterials are integral to the advancement of regenerative medicine, particularly in the realm of cartilage repair. They provide structural and biochemical support that is essential for the regeneration of damaged cartilage, and ongoing research continues to explore new materials and strategies to enhance their efficacy in clinical applications[43][44][45].

4.4 Organ and Tissue Engineering ​

Biomaterials play a crucial role in regenerative medicine, particularly in the fields of organ and tissue engineering. Their applications are diverse and encompass various strategies aimed at restoring normal function to damaged tissues and organs. This overview highlights key aspects of biomaterials' roles in regenerative medicine, focusing on their utilization in tissue engineering.

One primary application of biomaterials in regenerative medicine is their use as scaffolds that provide three-dimensional templates mimicking the extracellular matrix (ECM) of tissues. These scaffolds facilitate cell adhesion, proliferation, and differentiation, thereby promoting tissue regeneration. Biomaterials can be categorized into three main groups: naturally derived materials, synthetic polymers, and decellularized organ or tissue scaffolds. Each category has unique properties that can be exploited for specific tissue regeneration purposes, including hydrogels, nanofibers, and 3D scaffolds [16].

In cardiac tissue engineering, for instance, biomaterials are employed to create scaffolds for cellular transplantation, enhance angiogenesis, and influence cell migration. The design of these biomaterials aims to mimic the microenvironment of cardiac tissue in vivo, which is critical for determining the fate of transplanted stem cells and inducing cardiac lineage-oriented differentiation [4]. This indicates that biomaterials not only serve as physical supports but also actively participate in biochemical signaling that directs cellular behavior.

Furthermore, the emergence of bioglass and nano bioglass has marked significant advancements in the therapeutic and regenerative applications of biomaterials. These materials have been shown to rejuvenate tissues, facilitate regeneration, and deliver biomolecules into cells, demonstrating their versatility across various medical fields, including dentistry and cardiovascular applications [46]. The incorporation of metal ions into bioglass has enhanced its properties, making it suitable for a wide range of regenerative applications.

The trend toward in situ tissue regeneration has gained momentum, where biomaterials are utilized to harness the body's own stem/progenitor cells for tissue repair. Immunomodulatory biomaterials are designed to create a regenerative environment, recruit resident stem cells to the sites of injury, and guide their activities towards tissue regeneration [47]. This approach minimizes the need for ex vivo cell manipulation, taking advantage of the natural healing processes of the body.

In reproductive tissue engineering, biomaterials are developed to support the in vitro generation and culture of reproductive cells, as well as the transplantation and regeneration of reproductive tissues. The challenge lies in designing biomaterials that possess the appropriate mechanical properties, structure, and biological functionality tailored to the specific needs of reproductive tissues [48].

Additionally, the integration of nanotechnology into biomaterials has opened new avenues for enhancing tissue engineering outcomes. Nanostructured biomaterials can mimic the microstructure of tissues and provide specific cues that stimulate cellular activities such as adhesion and differentiation. These materials are crucial for developing scaffolds that not only support physical tissue structure but also influence biological processes [49].

Overall, the application of biomaterials in regenerative medicine represents a rapidly evolving field with the potential to address various clinical challenges associated with tissue and organ damage. The continuous advancements in biomaterial design and synthesis, along with a deeper understanding of cell-biomaterial interactions, are expected to lead to innovative solutions for effective tissue repair and regeneration.

5 Challenges and Future Directions ​

5.1 Material Selection and Design ​

Biomaterials are integral to the field of regenerative medicine, serving as scaffolds that facilitate the repair and regeneration of damaged tissues and organs. The evolving landscape of biomaterials has transitioned from inert supports to bioactive materials capable of triggering and promoting tissue regeneration. This transformation highlights the critical role of material selection and design in optimizing the efficacy of regenerative therapies.

The primary challenge in the selection and design of biomaterials lies in their ability to mimic the native extracellular matrix (ECM), which is essential for supporting cellular functions and influencing stem cell fate. Effective biomaterials must provide a conducive microenvironment that fosters cellular attachment, proliferation, and differentiation. Recent advancements have focused on creating materials that not only replicate the physical and chemical properties of natural tissues but also actively participate in biological processes. For instance, the incorporation of biologically active components into synthetic biomaterials can create a dynamic interaction with stem cells, akin to natural cellular microenvironments[3].

The design of biomaterials for regenerative applications also involves addressing their mechanical and biological properties. For example, in cardiac tissue engineering, biomaterials must be engineered to mimic the microenvironment of cardiac tissues, influencing the fate of transplanted stem cells and promoting cardiac lineage-oriented differentiation[4]. Moreover, the integration of nanotechnology has enabled the development of nanostructured biomaterials that can enhance cellular responses, such as attachment and differentiation, through their size and surface characteristics[1].

Future directions in biomaterials for regenerative medicine include the exploration of new material types, such as natural polymers, synthetic polymers, hydrogels, and nanomaterials. Each type presents unique advantages and challenges that must be carefully considered during the design process. For instance, hydrogels offer excellent biocompatibility and can be tailored to provide specific biochemical cues, while nanomaterials can be engineered to facilitate drug delivery and enhance tissue regeneration[6].

Additionally, the immune response to biomaterials is a critical factor that can influence the success of regenerative therapies. The foreign body response (FBR) can impact tissue integration and regeneration, necessitating the design of biomaterials that can modulate this response favorably. Recent research has focused on understanding the interactions between biomaterials and immune cells, aiming to optimize biomaterial properties to promote a beneficial immune response[9].

In conclusion, the effective application of biomaterials in regenerative medicine hinges on a comprehensive understanding of material selection and design principles. Addressing the challenges associated with replicating the complex architecture and functions of natural tissues, while also considering the immune response, will be crucial for the successful translation of biomaterials into clinical applications. Continued interdisciplinary research is essential to innovate and refine biomaterials that can meet the demands of regenerative medicine, paving the way for advanced therapeutic solutions[12][16][50].

5.2 Regulatory Hurdles ​

Biomaterials play a crucial role in regenerative medicine by serving as scaffolds that facilitate tissue repair and regeneration. Their applications span various domains, including stem cell therapy, tissue engineering, and the development of medical devices. However, the clinical uptake of biomaterials is hindered by several challenges, including regulatory hurdles.

One of the primary challenges in the use of biomaterials in regenerative medicine is the complex regulatory process required to demonstrate their safety and efficacy. As of 2020, only nine synthetic biodegradable polymers have been cleared or approved for use in medical devices in the United States, highlighting the limited number of biomaterials that have successfully navigated the regulatory landscape [18]. This limited availability can be attributed to the stringent evaluation standards, such as ISO-10993, which assess the host response to biomaterials but often fail to predict in vivo acceptance accurately [51].

Furthermore, the immune response to biomaterials poses significant challenges. Adverse effects commonly exhibited by patients, such as inflammation and rejection, are primarily due to the host immune response to the implanted materials. Despite advancements in biomaterial design, the interaction between biomaterials and the immune system remains poorly understood. For instance, endotoxin contamination in biomaterials can significantly affect their performance and the success of tissue engineering applications [51]. There is a pressing need for standardized in vitro pathways to evaluate the immune response to biomaterials, which could enhance the predictability of clinical outcomes [51].

Another significant barrier is the design limitations of current biomaterials, which often do not adequately support the biological processes necessary for effective tissue regeneration. The mechanical and degradation properties of many biodegradable polymers used in medical devices are suboptimal, limiting their functionality in regenerative applications [18]. Additionally, the requirement for biomaterials to be tailored to specific biological parameters complicates their design and application [52].

Looking towards the future, there is a need for innovative approaches to biomaterial development that address these challenges. Recent advancements in nanotechnology have shown promise in enhancing the properties of biomaterials. For example, the integration of nanoparticles into biomaterials can improve biocompatibility and facilitate better interactions with target cells [52]. Furthermore, the exploration of immunomodulatory biomaterials that can mitigate the foreign body response presents an exciting avenue for improving the integration and efficacy of implanted devices [22].

In summary, while biomaterials hold significant potential in regenerative medicine, their clinical application is currently limited by regulatory hurdles, challenges in immune response management, and design constraints. Future research should focus on developing advanced biomaterials that not only meet regulatory requirements but also enhance therapeutic outcomes through improved biocompatibility and functionality. The evolution of biomaterials will be critical in realizing the full potential of regenerative medicine.

5.3 Emerging Technologies and Innovations ​

Biomaterials play a pivotal role in regenerative medicine, serving as essential components in various therapeutic applications aimed at restoring or replacing damaged tissues and organs. The advancements in biomaterials have led to significant improvements in the efficacy of regenerative therapies, although several challenges remain, and future directions are continuously evolving.

Biomaterials are designed to support cellular functions and influence the fate of stem cells through biochemical and physical cues. They serve as scaffolds that can enhance stem cell differentiation, promote tissue engineering, and facilitate cellular transplantation. For instance, recent advancements have been made in the development of biomaterials that mimic the microenvironment of specific tissues, thereby influencing stem cell behavior and promoting targeted differentiation pathways (Shao et al. 2025) [6]. Various types of biomaterials, including natural and synthetic polymers, hydrogels, and nanomaterials, are utilized to create microenvironments conducive to tissue regeneration (Shao et al. 2025) [6].

In the context of pain management, biomaterials are being explored to enhance the efficacy of conventional pharmacotherapy and provide non-pharmacological alternatives for chronic pain. Novel regenerative biomaterials have been designed to incorporate biochemical and physical pro-regenerative cues, thereby improving the localization and controlled delivery of analgesic agents. These advancements allow for sustained and targeted delivery, leading to improved treatment efficacy and reduced dosage requirements (Gu et al. 2022) [53].

Despite the progress, challenges persist in the field of biomaterials and regenerative medicine. One significant challenge is the engineering of biomaterials that can adequately match both the mechanical and biological contexts of the target tissues. The need for vascularization in large tissue constructs is also a critical factor that must be addressed (Tang et al. 2021) [31]. Additionally, the potential for immune rejection and the need for long-term biocompatibility and degradation rates of biomaterials remain areas of concern (Qi et al. 2015) [54].

Emerging technologies and innovations in biomaterials are continuously shaping the future of regenerative medicine. For example, the integration of nanotechnology has led to the development of nanostructured biomaterials that can interact with biological systems at the nanoscale, enhancing tissue regeneration and repair (Verma et al. 2011) [55]. These nanobiomaterials can be tailored to create specific microenvironments that facilitate cell attachment, proliferation, and differentiation, thereby overcoming some of the limitations of traditional biomaterials (Kumar et al. 2020) [56].

Moreover, advancements in 3D bioprinting technologies are enabling the fabrication of complex tissue structures that can more closely mimic the architecture of natural tissues. This innovative approach holds promise for creating functional tissue constructs that can be used in clinical applications (Cao et al. 2022) [50].

In summary, biomaterials are integral to the advancement of regenerative medicine, with ongoing innovations addressing existing challenges and paving the way for new therapeutic strategies. The future of this field will likely involve further integration of emerging technologies, enhancing the capabilities of biomaterials to support tissue regeneration and improve clinical outcomes.

6 Conclusion ​

The findings presented in this review underscore the transformative potential of biomaterials in the field of regenerative medicine. The categorization of biomaterials into natural, synthetic, and composite types highlights their unique properties and roles in facilitating tissue repair and regeneration. Current research has demonstrated that biomaterials can enhance biocompatibility, promote cellular interactions, and serve as effective drug delivery systems, all of which are crucial for successful tissue integration. Despite the progress made, challenges remain, particularly regarding material selection, regulatory hurdles, and the need for innovative technologies. Future research directions should focus on optimizing biomaterial design to better mimic the extracellular matrix, understanding immune responses, and leveraging emerging technologies such as nanotechnology and 3D bioprinting. By addressing these challenges, biomaterials have the potential to revolutionize regenerative medicine, leading to improved therapeutic strategies and better patient outcomes.

References ​

  • [1] Guobao Wei;Peter X Ma. Nanostructured Biomaterials for Regeneration.. Advanced functional materials(IF=19.0). 2008. PMID:19946357. DOI: 10.1002/adfm.200800662.
  • [2] Jiajun Qiu;Xuanyong Liu. Nanostructured Biomaterials for Tissue Repair and Anti-Infection.. Nanomaterials (Basel, Switzerland)(IF=4.3). 2022. PMID:35564282. DOI: 10.3390/nano12091573.
  • [3] Fa-Ming Chen;Xiaohua Liu. Advancing biomaterials of human origin for tissue engineering.. Progress in polymer science(IF=26.1). 2016. PMID:27022202. DOI: 10.1016/j.progpolymsci.2015.02.004.
  • [4] Raja Ghazanfar Ali Sahito;Poornima Sureshkumar;Isaia Sotiriadou;Sureshkumar Perumal Srinivasan;Davood Sabour;Jürgen Hescheler;Kurt Pfannkuche;Agapios Sachinidis. The Potential Application of Biomaterials in Cardiac Stem Cell Therapy.. Current medicinal chemistry(IF=3.5). 2016. PMID:26951086. DOI: 10.2174/092986732306160303151041.
  • [5] Anna M Brokesh;Akhilesh K Gaharwar. Inorganic Biomaterials for Regenerative Medicine.. ACS applied materials & interfaces(IF=8.2). 2020. PMID:31989815. DOI: 10.1021/acsami.9b17801.
  • [6] Mingchen Shao;Mohamad Rahmdel;Sepideh Karkon Shayan;Elham Hassannia;Mohammad Khedmatgozar;Khadije Yousefi;Payam Ali-Khiavi;Ahmed Hjazi;Raed Fanoukh Aboqader Al-Aouadi;Paria Arjmandi Sarvestani;Mohammad Reza Ghasemzadeh Fard;Mehrdad Nourizadeh;Saeid Shabestari Khiabani;Muath Suliman;Paria Ganji Nataj;Sina Hamzehzadeh. Advancements in Biomaterials for Stem Cell Differentiation.. Stem cell reviews and reports(IF=4.2). 2025. PMID:40257542. DOI: 10.1007/s12015-025-10879-8.
  • [7] Ziryan Othman;Berta Cillero Pastor;Sabine van Rijt;Pamela Habibovic. Understanding interactions between biomaterials and biological systems using proteomics.. Biomaterials(IF=12.9). 2018. PMID:29571054. DOI: 10.1016/j.biomaterials.2018.03.020.
  • [8] Teruki Nii;Yoshiki Katayama. Biomaterial-Assisted Regenerative Medicine.. International journal of molecular sciences(IF=4.9). 2021. PMID:34445363. DOI: 10.3390/ijms22168657.
  • [9] Tim Ten Brink;Febriyani Damanik;Joris I Rotmans;Lorenzo Moroni. Unraveling and Harnessing the Immune Response at the Cell-Biomaterial Interface for Tissue Engineering Purposes.. Advanced healthcare materials(IF=9.6). 2024. PMID:38217464. DOI: 10.1002/adhm.202301939.
  • [10] C James Kirkpatrick. Modelling the regenerative niche: a major challenge in biomaterials research.. Regenerative biomaterials(IF=8.1). 2015. PMID:26816650. DOI: 10.1093/rb/rbv018.
  • [11] Dalila Di Francesco;Diego Mantovani;George Hussey;Francesca Boccafoschi. Matrix bound nanovesicles: A great promise for TERM in less than a decade of research.. Matrix biology : journal of the International Society for Matrix Biology(IF=4.8). 2025. PMID:41046877. DOI: 10.1016/j.matbio.2025.10.001.
  • [12] Francesca Camponogara;Federica Zanotti;Martina Trentini;Elena Tiengo;Ilaria Zanolla;Elham Pishavar;Elisa Soliani;Marco Scatto;Paolo Gargiulo;Ylenia Zambito;Stefano De Luca;Letizia Ferroni;Barbara Zavan. Biomaterials for Regenerative Medicine in Italy: Brief State of the Art of the Principal Research Centers.. International journal of molecular sciences(IF=4.9). 2022. PMID:35897825. DOI: 10.3390/ijms23158245.
  • [13] Sha Huang;Xiaobing Fu. Naturally derived materials-based cell and drug delivery systems in skin regeneration.. Journal of controlled release : official journal of the Controlled Release Society(IF=11.5). 2010. PMID:19850093. DOI: 10.1016/j.jconrel.2009.10.018.
  • [14] Nur Izzah Md Fadilah;Shou Jin Phang;Nurkhuzaiah Kamaruzaman;Atiqah Salleh;Mazlan Zawani;Arka Sanyal;Manira Maarof;Mh Busra Fauzi. Antioxidant Biomaterials in Cutaneous Wound Healing and Tissue Regeneration: A Critical Review.. Antioxidants (Basel, Switzerland)(IF=6.6). 2023. PMID:37107164. DOI: 10.3390/antiox12040787.
  • [15] Leticia Ramos Dantas;Gabriel Burato Ortis;Paula Hansen Suss;Felipe Francisco Tuon. Advances in Regenerative and Reconstructive Medicine in the Prevention and Treatment of Bone Infections.. Biology(IF=3.5). 2024. PMID:39194543. DOI: 10.3390/biology13080605.
  • [16] Daniela Steffens;Daikelly I Braghirolli;Natasha Maurmann;Patricia Pranke. Update on the main use of biomaterials and techniques associated with tissue engineering.. Drug discovery today(IF=7.5). 2018. PMID:29608960. DOI: 10.1016/j.drudis.2018.03.013.
  • [17] Peter X Ma. Biomimetic materials for tissue engineering.. Advanced drug delivery reviews(IF=17.6). 2008. PMID:18045729. DOI: 10.1016/j.addr.2007.08.041.
  • [18] Huifeng Wang;Samantha Huddleston;Jian Yang;Guillermo A Ameer. Enabling Proregenerative Medical Devices via Citrate-Based Biomaterials: Transitioning from Inert to Regenerative Biomaterials.. Advanced materials (Deerfield Beach, Fla.)(IF=26.8). 2024. PMID:38043945. DOI: 10.1002/adma.202306326.
  • [19] Stelios T Andreadis;David J Geer. Biomimetic approaches to protein and gene delivery for tissue regeneration.. Trends in biotechnology(IF=14.9). 2006. PMID:16716420. DOI: 10.1016/j.tibtech.2006.05.001.
  • [20] Narcisa Babeanu;Nicoleta Radu;Cristina-Emanuela Enascuta;Elvira Alexandrescu;Mihaela Ganciarov;Mohammed Shaymaa Omar Mohammed;Ioana Raluca Suica-Bunghez;Raluca Senin;Magdalina Ursu;Marinela Bostan. Obtaining and Characterizing Composite Biomaterials of Animal Resources with Potential Applications in Regenerative Medicine.. Polymers(IF=4.9). 2022. PMID:36080619. DOI: 10.3390/polym14173544.
  • [21] A N Cormack;A Tilocca. Structure and biological activity of glasses and ceramics.. Philosophical transactions. Series A, Mathematical, physical, and engineering sciences(IF=3.7). 2012. PMID:22349242. DOI: 10.1098/rsta.2011.0371.
  • [22] Alexia Kim;Mauricio A Downer;Charlotte E Berry;Caleb Valencia;Alex Z Fazilat;Michelle Griffin. Investigating Immunomodulatory Biomaterials for Preventing the Foreign Body Response.. Bioengineering (Basel, Switzerland)(IF=3.7). 2023. PMID:38136002. DOI: 10.3390/bioengineering10121411.
  • [23] Maria Karkanitsa;Parinaz Fathi;Tran Ngo;Kaitlyn Sadtler. Mobilizing Endogenous Repair Through Understanding Immune Reaction With Biomaterials.. Frontiers in bioengineering and biotechnology(IF=4.8). 2021. PMID:34917594. DOI: 10.3389/fbioe.2021.730938.
  • [24] Wenhui Liu;Lihua Zu;Shanzheng Wang;Jingyao Li;Xiaoyuan Fei;Meng Geng;Chunlei Zhu;Hui Shi. Tailored biomedical materials for wound healing.. Burns & trauma(IF=9.6). 2023. PMID:37899884. DOI: 10.1093/burnst/tkad040.
  • [25] Ayan Nurkesh;Alexandr Jaguparov;Shiro Jimi;Arman Saparov. Recent Advances in the Controlled Release of Growth Factors and Cytokines for Improving Cutaneous Wound Healing.. Frontiers in cell and developmental biology(IF=4.3). 2020. PMID:32760728. DOI: 10.3389/fcell.2020.00638.
  • [26] Murugan Prasathkumar;Subramaniam Sadhasivam. Chitosan/Hyaluronic acid/Alginate and an assorted polymers loaded with honey, plant, and marine compounds for progressive wound healing-Know-how.. International journal of biological macromolecules(IF=8.5). 2021. PMID:34271047. DOI: 10.1016/j.ijbiomac.2021.07.067.
  • [27] Qingxin Wu;Yibing You;Haiyan Hu;Lantao Wang;Zhengfeng Lu;Xiaofei Qin. Living biomaterials: A promising approach to promoting wound healing.. Biomaterials advances(IF=6.0). 2025. PMID:41232244. DOI: 10.1016/j.bioadv.2025.214599.
  • [28] Gurvinder Kaur;Ganesh Narayanan;Deepa Garg;Abhay Sachdev;Ishita Matai. Biomaterials-Based Regenerative Strategies for Skin Tissue Wound Healing.. ACS applied bio materials(IF=4.7). 2022. PMID:35451829. DOI: 10.1021/acsabm.2c00035.
  • [29] Variksha Singh;Thashree Marimuthu;Maya M Makatini;Yahya E Choonara. Biopolymer-Based Wound Dressings with Biochemical Cues for Cell-Instructive Wound Repair.. Polymers(IF=4.9). 2022. PMID:36559739. DOI: 10.3390/polym14245371.
  • [30] Zhengyuan Liu;Junnan Xu;Xing Wang. Bioactive hemostatic materials: a new strategy for promoting wound healing and tissue regeneration.. MedComm(IF=10.7). 2025. PMID:40123833. DOI: 10.1002/mco2.70113.
  • [31] Guoke Tang;Zhiqin Liu;Yi Liu;Jiangming Yu;Xing Wang;Zhihong Tan;Xiaojian Ye. Recent Trends in the Development of Bone Regenerative Biomaterials.. Frontiers in cell and developmental biology(IF=4.3). 2021. PMID:34026758. DOI: 10.3389/fcell.2021.665813.
  • [32] Qin Zhao;Yueqi Ni;Hongjiang Wei;Yiling Duan;Jingqiu Chen;Qi Xiao;Jie Gao;Yiqian Yu;Yu Cui;Simin Ouyang;Richard J Miron;Yufeng Zhang;Chengtie Wu. Ion incorporation into bone grafting materials.. Periodontology 2000(IF=15.7). 2024. PMID:37823468. DOI: 10.1111/prd.12533.
  • [33] Hadi Hajiali;Liliang Ouyang;Virginia Llopis-Hernandez;Oana Dobre;Felicity R A J Rose. Review of emerging nanotechnology in bone regeneration: progress, challenges, and perspectives.. Nanoscale(IF=5.1). 2021. PMID:34085085. DOI: 10.1039/d1nr01371h.
  • [34] Ruyi Shao;Yongqiang Dong;Songou Zhang;Xudong Wu;Xiaogang Huang;Bin Sun;Bin Zeng;Fangming Xu;Wenqing Liang. State of the art of bone biomaterials and their interactions with stem cells: Current state and future directions.. Biotechnology journal(IF=3.1). 2022. PMID:35073451. DOI: 10.1002/biot.202100074.
  • [35] Jinkyu Lee;Hayeon Byun;Sajeesh Kumar Madhurakkat Perikamana;Sangmin Lee;Heungsoo Shin. Current Advances in Immunomodulatory Biomaterials for Bone Regeneration.. Advanced healthcare materials(IF=9.6). 2019. PMID:30328293. DOI: 10.1002/adhm.201801106.
  • [36] Domingo Cesar Carrascal-Hernández;Juan Pablo Martínez-Cano;Juan David Rodríguez Macías;Carlos David Grande-Tovar. Evolution in Bone Tissue Regeneration: From Grafts to Innovative Biomaterials.. International journal of molecular sciences(IF=4.9). 2025. PMID:40362478. DOI: 10.3390/ijms26094242.
  • [37] Mingkai Wang;Yan Wu;Guangfeng Li;Qiushui Lin;Wencai Zhang;Han Liu;Jiacan Su. Articular cartilage repair biomaterials: strategies and applications.. Materials today. Bio(IF=10.2). 2024. PMID:38269053. DOI: 10.1016/j.mtbio.2024.100948.
  • [38] Esther J Lee;F Kurtis Kasper;Antonios G Mikos. Biomaterials for tissue engineering.. Annals of biomedical engineering(IF=5.4). 2014. PMID:23820768. DOI: 10.1007/s10439-013-0859-6.
  • [39] Louis Kluyskens;Pedro Debieux;Keng Lin Wong;Aaron J Krych;Daniel B F Saris. Biomaterials for meniscus and cartilage in knee surgery: state of the art.. Journal of ISAKOS : joint disorders & orthopaedic sports medicine(IF=3.3). 2022. PMID:35543667. DOI: 10.1136/jisakos-2020-000600.
  • [40] Huiqun Zhou;Zhen Zhang;Yulei Mu;Hang Yao;Yi Zhang;Dong-An Wang. Harnessing Nanomedicine for Cartilage Repair: Design Considerations and Recent Advances in Biomaterials.. ACS nano(IF=16.0). 2024. PMID:38592060. DOI: 10.1021/acsnano.4c00780.
  • [41] Wei Seong Toh;Myron Spector;Eng Hin Lee;Tong Cao. Biomaterial-mediated delivery of microenvironmental cues for repair and regeneration of articular cartilage.. Molecular pharmaceutics(IF=4.5). 2011. PMID:21500855. DOI: 10.1021/mp100437a.
  • [42] Amos Matsiko;Tanya J Levingstone;Fergal J O'Brien. Advanced Strategies for Articular Cartilage Defect Repair.. Materials (Basel, Switzerland)(IF=3.2). 2013. PMID:28809332. DOI: 10.3390/ma6020637.
  • [43] Aziz Eftekhari;Solmaz Maleki Dizaj;Simin Sharifi;Sara Salatin;Yalda Rahbar Saadat;Sepideh Zununi Vahed;Mohammad Samiei;Mohammadreza Ardalan;Maryam Rameshrad;Elham Ahmadian;Magali Cucchiarini. The Use of Nanomaterials in Tissue Engineering for Cartilage Regeneration; Current Approaches and Future Perspectives.. International journal of molecular sciences(IF=4.9). 2020. PMID:31947685. DOI: 10.3390/ijms21020536.
  • [44] Ok Hee Jeon;Jennifer Elisseeff. Orthopedic tissue regeneration: cells, scaffolds, and small molecules.. Drug delivery and translational research(IF=5.5). 2016. PMID:26625850. DOI: 10.1007/s13346-015-0266-7.
  • [45] Zhanqi Wei;Ganlin Zhang;Qing Cao;Tianhao Zhao;Yixin Bian;Wei Zhu;Xisheng Weng. Recent Developments and Current Applications of Organic Nanomaterials in Cartilage Repair.. Bioengineering (Basel, Switzerland)(IF=3.7). 2022. PMID:36004915. DOI: 10.3390/bioengineering9080390.
  • [46] Lakshmi Krishnan;Pulasta Chakrabarty;Kavitha Govarthanan;Suresh Rao;Tuhin Subhra Santra. Bioglass and nano bioglass: A next-generation biomaterial for therapeutic and regenerative medicine applications.. International journal of biological macromolecules(IF=8.5). 2024. PMID:38880457. DOI: 10.1016/j.ijbiomac.2024.133073.
  • [47] Ingrid Safina;Mildred C Embree. Biomaterials for recruiting and activating endogenous stem cells in situ tissue regeneration.. Acta biomaterialia(IF=9.6). 2022. PMID:35292413. DOI: 10.1016/j.actbio.2022.03.014.
  • [48] Xuemin Liu;Kai Wu;Liang Gao;Liping Wang;Xuetao Shi. Biomaterial strategies for the application of reproductive tissue engineering.. Bioactive materials(IF=20.3). 2022. PMID:35310354. DOI: 10.1016/j.bioactmat.2021.11.023.
  • [49] Feng Han;Qingchen Meng;En Xie;Kexin Li;Jie Hu;Qianglong Chen;Jiaying Li;Fengxuan Han. Engineered biomimetic micro/nano-materials for tissue regeneration.. Frontiers in bioengineering and biotechnology(IF=4.8). 2023. PMID:37469449. DOI: 10.3389/fbioe.2023.1205792.
  • [50] Dinglingge Cao;Jiandong Ding. Recent advances in regenerative biomaterials.. Regenerative biomaterials(IF=8.1). 2022. PMID:36518879. DOI: 10.1093/rb/rbac098.
  • [51] Daniel Salthouse;Katarina Novakovic;Catharien M U Hilkens;Ana Marina Ferreira. Interplay between biomaterials and the immune system: Challenges and opportunities in regenerative medicine.. Acta biomaterialia(IF=9.6). 2023. PMID:36356914. DOI: 10.1016/j.actbio.2022.11.003.
  • [52] Angelika Kwiatkowska;Anna Grzeczkowicz;Agata Lipko;Beata Kazimierczak;Ludomira H Granicka. Emerging Approaches to Mitigate Neural Cell Degeneration with Nanoparticles-Enhanced Polyelectrolyte Systems.. Membranes(IF=3.6). 2025. PMID:41149991. DOI: 10.3390/membranes15100313.
  • [53] Xingjian Gu;Michelle A Carroll Turpin;Mario I Romero-Ortega. Biomaterials and Regenerative Medicine in Pain Management.. Current pain and headache reports(IF=3.5). 2022. PMID:35727489. DOI: 10.1007/s11916-022-01055-5.
  • [54] Chunxiao Qi;Xiaojun Yan;Chenyu Huang;Alexander Melerzanov;Yanan Du. Biomaterials as carrier, barrier and reactor for cell-based regenerative medicine.. Protein & cell(IF=12.8). 2015. PMID:26088192. DOI: 10.1007/s13238-015-0179-8.
  • [55] Shalini Verma;Abraham J Domb;Neeraj Kumar. Nanomaterials for regenerative medicine.. Nanomedicine (London, England)(IF=3.9). 2011. PMID:21182426. DOI: 10.2217/nnm.10.157.
  • [56] Pawan Kumar;Meenu Saini;Brijnandan S Dehiya;Anil Sindhu;Vinod Kumar;Ravinder Kumar;Luciano Lamberti;Catalin I Pruncu;Rajesh Thakur. Comprehensive Survey on Nanobiomaterials for Bone Tissue Engineering Applications.. Nanomaterials (Basel, Switzerland)(IF=4.3). 2020. PMID:33066127. DOI: 10.3390/nano10102019.

MaltSci Intelligent Research Services ​

Search for more papers on MaltSci.com ​

Biomaterials · Regenerative Medicine · Tissue Engineering · Biocompatibility · Drug Delivery

© 2025 MaltSci